• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病活动性葡萄膜炎的荧光素血管造影与视力

Fluorescein angiography and visual acuity in active uveitis with Behçet disease.

作者信息

Yu Hyeong Gon, Kim Moon Jung, Oh Frederick Sewoong

机构信息

Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.

出版信息

Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):41-6. doi: 10.1080/09273940802553279.

DOI:10.1080/09273940802553279
PMID:19294573
Abstract

PURPOSE

To determine the association of fluorescein angiography characteristics with visual acuity and visual loss during medical treatment in patients with Behçet uveitis.

METHODS

Ninety-three eyes from 69 Behçet patients with active panuveitis underwent fluorescein angiography, and the characteristic findings by angiography were determined. The patients were followed with immunomodulatory treatment.

RESULTS

Diffuse vascular leakage (73.4%), diffuse macular leakage (66.0%), and disc leakage (52.7%) were the predominant angiographic findings on fluorescein angiography. Multivariate logistic regression analysis revealed that a macular window defect and disc neovascularization on fluorescein angiography were associated with poor visual acuity (<or= 20/200) (p < .05). The presence of macular ischemia on fluorescein angiography was significantly associated with the risk of visual loss (<or= 20/200) at 48 months post-treatment (p < .05).

CONCLUSIONS

These results suggest that fluorescein angiography may be helpful for predicting visual prognosis for Behçet patients with panuveitis.

摘要

目的

确定白塞氏葡萄膜炎患者接受药物治疗期间荧光素血管造影特征与视力及视力丧失之间的关联。

方法

对69例患有活动性全葡萄膜炎的白塞氏病患者的93只眼睛进行荧光素血管造影,并确定血管造影的特征性表现。对患者进行免疫调节治疗随访。

结果

荧光素血管造影的主要血管造影表现为弥漫性血管渗漏(73.4%)、弥漫性黄斑渗漏(66.0%)和视盘渗漏(52.7%)。多因素逻辑回归分析显示,荧光素血管造影上的黄斑窗缺损和视盘新生血管与视力差(≤20/200)相关(p<0.05)。荧光素血管造影上黄斑缺血的存在与治疗后48个月视力丧失(≤20/200)的风险显著相关(p<0.05)。

结论

这些结果表明,荧光素血管造影可能有助于预测白塞氏全葡萄膜炎患者的视力预后。

相似文献

1
Fluorescein angiography and visual acuity in active uveitis with Behçet disease.白塞病活动性葡萄膜炎的荧光素血管造影与视力
Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):41-6. doi: 10.1080/09273940802553279.
2
Ocular manifestations of late-onset behçet disease.迟发性贝切特病的眼部表现。
Ophthalmologica. 2011;225(1):21-6. doi: 10.1159/000318601. Epub 2010 Aug 7.
3
Visual prognosis and risk factors for korean patients with behcet uveitis.韩国白塞氏葡萄膜炎患者的视力预后及危险因素
Ophthalmologica. 2008;222(5):344-50. doi: 10.1159/000146080. Epub 2008 Jul 21.
4
Uveitis in Behçet disease: an analysis of 880 patients.白塞病中的葡萄膜炎:880例患者的分析
Am J Ophthalmol. 2004 Sep;138(3):373-80. doi: 10.1016/j.ajo.2004.03.022.
5
[Intravenous corticosteroid megadose treatment in ocular Behçet disease].
Bull Soc Belge Ophtalmol. 1996;262:95-103.
6
Macular ischaemia in Behçet's disease.白塞病中的黄斑缺血
Eye (Lond). 2000 Oct;14 Pt 5:717-20. doi: 10.1038/eye.2000.190.
7
Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.白塞氏视网膜血管炎中荧光素血管造影结果与视力的相关性
Yonsei Med J. 2015 Jul;56(4):1087-96. doi: 10.3349/ymj.2015.56.4.1087.
8
Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.多灶性脉络膜炎伴全葡萄膜炎的眼部并发症发生率及视力丧失情况。
Ophthalmology. 2006 Dec;113(12):2310-6. doi: 10.1016/j.ophtha.2006.05.067. Epub 2006 Sep 25.
9
Behçet disease: visual prognosis and factors influencing the development of visual loss.白塞病:视觉预后和影响视力丧失发展的因素。
Am J Ophthalmol. 2011 Dec;152(6):1059-66. doi: 10.1016/j.ajo.2011.05.032. Epub 2011 Aug 26.
10
Vitrectomy for persistent panuveitis in Behçet's disease.白塞病持续性全葡萄膜炎的玻璃体切除术
Ocul Immunol Inflamm. 2005 Dec;13(6):447-53. doi: 10.1080/09273940591004232.

引用本文的文献

1
Fern-Like Pattern on Ultra-Widefield Fluorescein Angiography Across Various Uveitic Conditions.超广角荧光素血管造影在各种葡萄膜炎病症中呈现的蕨样形态
Rom J Ophthalmol. 2025 Jan-Mar;69(1):101-109. doi: 10.22336/rjo.2025.16.
2
The Current and Novel Imaging Modalities for Ocular Vasculitis in Behcet's Disease: A Review.白塞病眼部血管炎的当前及新型成像方式:综述
Cureus. 2024 Sep 16;16(9):e69528. doi: 10.7759/cureus.69528. eCollection 2024 Sep.
3
Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.
贝赫切特葡萄膜炎的解码:发病机制和治疗进展的深入综述。
J Neuroinflammation. 2024 May 22;21(1):133. doi: 10.1186/s12974-024-03123-6.
4
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies.优化贝赫切特葡萄膜炎的管理:个性化免疫抑制策略的综述。
Med Sci Monit. 2024 May 7;30:e943240. doi: 10.12659/MSM.943240.
5
Investigation of optic nerve function in Behçet's patients with optic disc hyperfluorescence in fundus fluorescein angiography.眼底荧光血管造影中视盘高荧光的 Behçet 患者视神经功能研究。
Int Ophthalmol. 2024 Feb 13;44(1):76. doi: 10.1007/s10792-024-02927-y.
6
Optimizing glucocorticoid therapy for Behçet's uveitis: efficacy, adverse effects, and advances in combination approaches.优化贝赫切特葡萄膜炎的糖皮质激素治疗:疗效、不良反应及联合治疗方法的进展。
Int Ophthalmol. 2023 Nov;43(11):4373-4381. doi: 10.1007/s10792-023-02808-w. Epub 2023 Jul 7.
7
Fluorescein angiographic findings and Behcet's disease ocular attack score 24 (BOS24) as prognostic factors for visual outcome in patients with ocular Behcet's disease.荧光素血管造影结果和白塞病眼部发作评分24(BOS24)作为白塞病性葡萄膜炎患者视力预后的预测因素。
Int J Retina Vitreous. 2021 Aug 28;7(1):48. doi: 10.1186/s40942-021-00318-4.
8
Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.贝赫切特葡萄膜炎:当前的诊断与治疗方法。
Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308.
9
Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis.感染性和非感染性葡萄膜炎的视网膜血管炎症和闭塞性改变。
Jpn J Ophthalmol. 2020 Mar;64(2):150-159. doi: 10.1007/s10384-020-00717-4. Epub 2020 Feb 3.
10
Automated quantification of foveal avascular zone and vascular density in Behçet's disease.贝切特病中中心凹无血管区和血管密度的自动量化。
Ir J Med Sci. 2020 Feb;189(1):349-354. doi: 10.1007/s11845-019-02051-2. Epub 2019 Jul 2.